Copyright
©The Author(s) 2019.
World J Gastroenterol. Jan 28, 2019; 25(4): 469-484
Published online Jan 28, 2019. doi: 10.3748/wjg.v25.i4.469
Published online Jan 28, 2019. doi: 10.3748/wjg.v25.i4.469
Table 1 Clinicopathologic factors of the confirmed carcinoma and non-carcinoma indefinite for neoplasm/dysplasia lesions reported at the initial forceps biopsy n (%)
Initial Dx | Total n = 461 | IFND | P value | |
Final Dx | Non-carcinoma n = 357 | Carcinoma n = 104 | ||
Sex | 0.816 | |||
Male | 319 (69.2) | 248 (69.5) | 71 (68.3) | |
Female | 142 (30.8) | 109 (30.5) | 33 (31.7) | |
Age (yr) | < 0.001 | |||
< 60 | 236 (51.2) | 204 (57.1) | 32 (30.8) | |
≥ 60 | 225 (48.8) | 153 (42.9) | 72 (69.2) | |
Endoscopic size (mm) | < 0.001 | |||
< 10 | 286 (62.0) | 251 (70.3) | 35 (33.7) | |
≥ 10 | 175 (38.0) | 106 (29.7) | 69 (66.3) | |
Location I | 0.914 | |||
Upper | 43 (9.3) | 34 (9.5) | 9 (8.7) | |
Middle | 122 (26.5) | 93 (26.1) | 29 (27.9) | |
Lower | 296 (64.2) | 230 (64.4 | 66 (63.5) | |
Location II | 0.744 | |||
Fundus | 9 (1.9) | 8 (2.2) | 1 (1.0) | |
Body | 122 (26.5) | 93 (26.1) | 29 (27.9) | |
Antrum | 277 (60.1) | 213 (59.7) | 64 (61.5) | |
Angle | 53 (11.5) | 43 (12.0) | 10 (9.6) | |
Location III | 0.267 | |||
Anterior wall | 75 (16.3) | 55 (15.4) | 20 (19.2) | |
Posterior wall | 76 (16.5) | 63 (17.6) | 13 (12.5) | |
Greater curvature | 85 (18.4) | 61 (17.1) | 24 (23.1) | |
Lesser curvature | 225 (48.8) | 178 (49.9) | 47 (45.2) | |
Gross type | 0.585 | |||
Elevated (type I and IIa) | 181 (39.3) | 136 (38.1) | 45 (43.3) | |
Flat (type IIb) | 168 (36.4) | 134 (37.5) | 34 (32.7) | |
Depressed (type IIc and III) | 112 (24.3) | 87 (24.4) | 25 (24.0) | |
Color change | 0.140 | |||
Redness | 314 (68.1) | 250 (70.0) | 64 (61.5) | |
Whitish | 58 (12.6) | 45 (12.6) | 13 (12.5) | |
No change | 89 (19.3) | 62 (17.4) | 27 (26.0) | |
Single lesion | < 0.001 | |||
No | 141 (30.6) | 134 (37.5) | 7 (6.7) | |
Yes | 320 (69.4) | 223 (62.5) | 97 (93.3) | |
Ulcer | 0.182 | |||
No | 334 (72.5) | 264 (73.9) | 70 (67.3) | |
Yes | 127 (27.5) | 93 (26.1) | 34 (32.7) | |
Spontaneous bleeding | < 0.001 | |||
No | 405 (87.9) | 332 (93.0) | 73 (70.2) | |
Yes | 56 (12.1) | 25 (7.0) | 31 (29.8) | |
Fold change | 0.206 | |||
No | 418 (90.7) | 327 (91.6) | 91 (87.5) | |
Yes | 43 (9.3) | 30 (8.4) | 13 (12.5) | |
Initial Bx | < 0.001 | |||
Regenerating atypia | 276 (59.9) | 267 (74.8) | 9 (8.7) | |
Atypical epithelium | 185 (40.1) | 90 (25.2) | 95 (91.3) | |
Repeated IFND | 0.002 | |||
No | 436 (94.6) | 344 (96.4) | 92 (88.5) | |
Yes | 25 (5.4) | 13 (3.6) | 12 (11.5) | |
Bx numbers at initial endoscopic Bx | 1.77 ± 1.13 | 2.15 ± 1.37 | 0.013 |
- Citation: Kwon MJ, Kang HS, Kim HT, Choo JW, Lee BH, Hong SE, Park KH, Jung DM, Lim H, Soh JS, Moon SH, Kim JH, Park HR, Min SK, Seo JW, Choe JY. Treatment for gastric ‘indefinite for neoplasm/dysplasia’ lesions based on predictive factors. World J Gastroenterol 2019; 25(4): 469-484
- URL: https://www.wjgnet.com/1007-9327/full/v25/i4/469.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i4.469